Hypoglycemic drugs.
There are an estimated 14 million individuals in the United States with diabetes mellitus. These individuals suffer a very high incidence of podiatric complications. This article focuses on the pharmacologic agents used in the management of hyperglycemia in the patient with diabetes mellitus, including insulin and sulfonylureas.
White
J R
JR
College of Pharmacy, Washington State University, Spokane.
Campbell
R K
RK
D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology / Q000517:prevention & control*; D007328:Insulin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000493:pharmacokinetics* / Q000627:therapeutic use
D007328:Insulin; D013453:Sulfonylurea Compounds